ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 22 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,677,750 | +1.3% | 16,850,000 | -4.3% | 0.28% | +18.0% |
| Q2 2023 | $8,569,440 | +5.0% | 17,600,000 | -14.6% | 0.23% | -16.8% |
| Q1 2023 | $8,159,660 | -22.9% | 20,600,000 | +5.1% | 0.28% | -4.4% |
| Q4 2022 | $10,584,000 | -0.9% | 19,600,000 | 0.0% | 0.29% | -1.3% |
| Q3 2022 | $10,682,000 | -1.8% | 19,600,000 | -2.0% | 0.30% | -11.3% |
| Q2 2022 | $10,875,000 | +2.4% | 20,000,000 | -4.8% | 0.34% | +56.5% |
| Q1 2022 | $10,618,000 | -9.7% | 21,000,000 | -6.7% | 0.21% | -10.8% |
| Q4 2021 | $11,756,000 | – | 22,500,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PenderFund Capital Management Ltd. | 29,679,000 | $23,720,000 | 7.42% |
| SILVERBACK ASSET MANAGEMENT LLC | 11,750,000 | $6,487,175 | 0.92% |
| DCF Advisers, LLC | 1,550,000 | $884,000 | 0.57% |
| Context Capital Management, LLC | 14,764 | $8,274,000 | 0.56% |
| AGF Investments LLC | 7,000,000 | $3,872,000 | 0.36% |
| WHITEBOX ADVISORS LLC | 19,600,000 | $10,682,000 | 0.30% |
| Pentwater Capital Management LP | 46,411,000 | $26,134,000 | 0.29% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 20,000,000 | $11,591,000 | 0.27% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 24,000,000 | $13,275,000 | 0.24% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 14,900,000 | $8,493,000 | 0.12% |